Introduction
The cytochromes P450 are a multigene family of microsomal hemoproteins. These enzymes are most prominent in the liver where they play a vital role in the biotransformation of such exogenous compounds as drugs, pesticides, and carcinogens. More than 15 different polypeptide forms of cytochrome P450 have been purified from rat liver, each differing in primary structure and, in some cases, in substrate specificity and in response to prototypic inducers such as phenobarbital, 3-methylcholanthrene, and steroids (1) . In certain instances, these cytochromes may catalyze the production of toxic or carcinogenic metabolites (2) , whereas in other cases cytochromes P450 protect by facilitating the elimination of potentially harmful foreign substances (3) .
Rats pretreated with the synthetic steroid pregnenolone16a-carbonitrile are resistent to the toxicity of many adminis-"catatoxic" (4) steroid significantly reduces the incidence of liver carcinomas in rats exposed to dimethylnitrosamine (5) . The molecular basis of this protective effect appears to involve induction of P-450p (6), the major form of cytochrome P-450 in the liver inducible by pregnenolone-16a-carbonitrile. Steroid hormones with glucocorticoid activity are also potent inducers of P-450p (7, 8) and of the cytochromes immunochemically related to P-450p that have been found in the livers of all mammals examined to date (9) . This extends to human liver which contains HLp, a glucocorticoid-inducible cytochrome P-450 orthologous to P-450p (10, 11) .
Cytochrome P-450-catalyzed biotransformations also occur in the intestinal mucosa where they may provide an important first line of defense against ingested toxins or carcinogens (12). However, little is known about the specific isozymes of cytochrome P-450 in the intestinal mucosa, their distribution within this tissue, or their regulation. This lack of information may be due to the difficulty in isolating microsomes from mucosal cells and to the belief that the concentrations of cytochrome P450 in this tissue are low as compared with those in liver.
Despite the intimate contact with potential carcinogens in the diet, the small bowel itself is remarkably resistent to spontaneous or experimental cancer formation (13). Having postulated a protective role for P-450p and HLp in liver (14) , we examined rat and human jejunal mucosa for related cytochromes with the use of specific antibodies and cloned complementary DNAs (cDNAs) as molecular probes. Our results reveal that cytochromes related to P-450p are remarkably abundant constituents of the jejunal mucosa of rats and man. Animals and treatments. Male Sprague-Dawley rats (250-275 g, Flow Laboratories, Inc., McLean, VA) were housed in pairs in wirebottom cages. They were given unlimited access to standard lab chow and tap water before the study, but only tap water during treatment intervals. Dexamethasone (20 mg/kg) suspended in corn oil was administered by gavage 24 and 2 h before decapitation. Control animals received corn oil alone. All animals were killed between 9 and 11 a.m.
Human subjects. Specimens of human liver and intestine were obtained from the operating room according to a protocol approved by the Committee for the Conduct of Human Research at the Medical College of Virginia. Patient numbers are used to designate liver specimens, some of which have been used in prior studies (10, 11, 14 Patient 17 was a 56-yr-old white male who became an organ donor shortly after incurring severe head trauma. His blood alcohol level on admission was 0.30% and 5 h before surgery he received intravenous dexamethasone (10 mg) and diphenylhydantoin (1 g ). He received furosemide (100 mg) and thorazine (100 mg) intraoperatively.
Samples of human intestine are designated in this report by letters A-K. Each of the patients A-F and H-K was morbidly obese, otherwise in good health, and taking no medications. Each patient received a single oral dQse (300 mg) ofcimetidine the evening before surgery (as part ofa separate, unrelated study). Patient G was an organ donor from whom historical details were unavailable.
Isolation ofintestinal mucosa cells. Al rats received ether anesthesia before decapitation. The segment ofjejunum (15 cm) immediately distal to the pyloric valve was excised and mucosal cells were isolated in buffers containing citrate and EDTA according to the technique of Weiser (15) with minor modifications. Solutions "A" and "B" were prepared as described (15) except phenylmethylsulfonylfluoride (40 ,ug/ml final concentration) was added. The lumen ofthe freshly excised jejunal segments were flushed with 50 cc of cold solution A. Each intestinal segment was ligated at its distal end and filled and drained twice with cold solution A. To isolate mucosal cells for immunochemical measurements, the segments were filled with solution A, incubated for 15 min at 37°C, then refilled with warmed solution B (37°C). The open end was clamped and the filled segments were submerged in solution B (37°C). The contents of each segment were drained and replaced with fresh solution B (37°C) at 5, 10, 20, 30, and 50 min. The mucosal cells dissociated from the intestinal lumen during each incubation were recovered by centrifugation (900 g, 5 min), which created five cell fractions that were numbered 1-5 in the order obtained. The isolated cells were washed twice in iced solution "C" (16) . This method has been shown to selectively remove mucosal cells, exclusive of interstitial and serosal cells, from the villus in a sequential manner beginning at the villus tip and progressing to the villus crypt (15 (16) . Each enterocyte fraction (pooled from four rats or one human specimen) was suspended in 2.5 cc of solution C (16) and was disrupted by sonication (35 s at 35 setting ofa dismembranator; Artek Systems Corp., Farmingdale, NY). The cell lysate was sedimented at 15,000 g for 10 min. The supernatant was transferred to a conical plastic tube; iced 52 mM calcium chloride solution (2.5 ml) was added; and, after standing on ice for 15 min, the microsomes were sedimented by centrifugation (2,000 g for 15 min). The pellet was resuspended in 2.5 ml of solution "D" (16) and enzymatic and spectral assays were performed immediately. The remaining microsomes were stored at -700C.
Immunoblot analyses. Immunoblots of intestinal and liver microsomes were carried out as previously described (18 fused with P3-X63-AG8 multiple myeloma cells and the resulting hybridoma was expanded in vitro. Individual clones were tested for antibody production by ELISA, allowed to expand, and then injected into female Balb/C mice (5 X 106 cells per mouse interperitoneally) that had been primed 2 wk previously with pristane (0.5 ml i.p.). The asitic fluid was collected 9 and 14 d later, and, after cells were removed by centrifugation, was stored at -70'C.
RNA isolation. The method of Chirgwin et al. (21) was used to isolate RNA from rat and human intestinal mucosal cells. Approximately I g of enterocytes (wet weight) was combined with 15 ml of an 10-mM Tris-HCl buffer (pH 7.4) containing 4 M guanidine thiocyanate and 7% fl-mercaptoethanol and lysed with a polytron (Brinkmann Instruments Co., Westbury, NY) for 20 s. The suspension was mixed with 1.6 ml of 20% sarcosyl, passed twice through a 22-gauge needle, and divided between two 1 5-ml sterile quickseal tubes. Cesium chloride (4.5 ml) was layered under the supernatant and the RNA was sedimented by centrifugation (100,000 g) for 16 hat 250C. The supernatant was removed, and the clear pellet was washed with ethanol and resuspended in 0.5 ml of sterile water. Total RNA content was estimated by absorbance at 260 nm. For all preparations, the ratio of the absorbances at 260/280 nm exceeded 1.8. Poly(A+) RNA was prepared by passing the total RNA through two cycles of oligo(dT)-cellulose chromatography.
Northern blot analyses. Total RNA or poly(A+) RNA from liver and intestine was subjected to electrophoresis in 1.0% agarose gels with 10 mM sodium phosphate buffer containing 1.1 M formaldehyde, and then transfered by blotting onto nitrocellulose. The nitrocellulose sheets were baked in vacuo for 2 h, incubated with salmon sperm DNA, and then hybridized for 12 h with cDNA labeled with 32P by nick translation. The filters were washed twice with 2X standard saline citrate (SSC), 0.1% sodium dodecyl sulfate at 25°C (15 min each), and once with 0.IX SSC, 0.1% sodium dodecyl sulfate for 15 min at 25°C followed by 15 min at 60°C. The hybridized bands were visualized by autoradiography. Preparation of the pDexl2 and Hp55s cDNAs have been previously described (9, 1 1). Chicken f3-actin cDNA (22) was a gift from Lola M. Reid, Albert Einstein Medical School, 1300 Morris Park Ave., Bronx, NY 10461.
Other assays. Erythromycin demethylase activity was determined by colorimetric measurement of formaldehyde formed (9, 23). Alkaline phosphatase activity was assayed in mucosal cell lysate (10 jug) with p-nitrophenol-phosphate serving as substrate (15) . Protein concentration was determined colorimetrically (24) . Total CO-binding hemoprotein was determined by difference spectroscopy (25) .
Results
Identification ofP-450p-related cytochromes in intestinal mucosa. With the protocols described in Methods it was possible to reproducibly prepare microsomes from villus tip cells from 15 cm of rat small bowel (immediately distal to the pyloric valve) or from 2 cm of human jejunum. Villus tip cell microsomes prepared from the jejunum of an organ donor (patient G) readily catalyzed the demethylation of erythromycin (Fig.  1) , an activity highly characteristic of P-450p and HLp in hepatic microsomes from rats and humans, respectively (10, 26) . Furthermore, this enzymatic activity could be inhibited (75%) by incubating the human intestinal microsomes with anti-P450p IgG, an antibody that reacts with hepatic glucocorticoidinducible cytochromes of several mammals (9), including humans (10) (Fig. 1) . This result mirrors the immunoinhibition of erythromycin demethylase activity in human liver microsomes (10) . In contrast, preincubation of human intestinal microsomes with nonimmune IgG or with antibodies raised to other forms of cytochrome P-450 (P-450c or P-450b [27]) failed to inhibit erythromycin demethylase activity significantly (Fig. 1) . Microsomes prepared from rat jejunum enter- ocytes also catalyzed erythromycin demethylation, and this activity was inhibited similarly by anti-P-450p IgG (data not shown).
For immunochemical analysis, intestinal microsomes prepared from the villus tip cells were subjected to electrophoresis in sodium dodecyl sulfate-polyacrylamide gels and analyzed on immunoblots developed with anti-P-450p IgG. In both the rat and human samples, this polyclonal antibody reacted with only a single protein band that comigrated with purified P-450p (data not shown). These experiments were extended by developing immunoblots with a monoclonal antibody, 1G8, that reacts with purified P-450p (Fig. 2 A, lane P-450p) but not with purified HLp (Fig. 2 A, (Fig. 2 A, lane Int) indistinguishable from that of purified P-450p or of immunoreactive P-450p in liver microsomes prepared from untreated male rats (Fig. 2 A, lane ML) . As we observed previously with the use of form-specific anti-P-450p IgG (9), 1G8 recognized no proteins in liver microsomes prepared from untreated female rats (Fig. 2 A, lane FL) . In another study (28) , we have shown that liver microsomes of male rats contain, in addition to P-450p, a second glucocorticoid-inducible protein recognized by 1G8 (not readily appreciated from Fig. 2 A) ; however, repeated analyses ofthe immunoblots of intestinal microsomes did not reveal a second 1G8-reactive protein. Next, we tested a monoclonal antibody, 13-7-10, that does not recognize purified P-450p (Fig. 2 B , lane P-450p) but does react with HLp ( Fig. 2 B, lane HLp) . Monoclonal antibody 13-7-10 recognized a male rat intestinal protein (Fig. 2 B , lane marked Int) although its mobility was not the same as the 13-7-10-reactive protein found in male rat liver ( Fig. 2 B, lane ML) . Rather, the mobility of the 13-7-10-reactive protein in the intestine matched that of a glucocorticoid-inducible 13-7-10-reactive protein in the liver of female rats (28) (Fig. 2 B, lane FL) . When the lane containing the blotted intestinal proteins was cut lengthwise and the halves separately developed with 1G8 or 13-7-10, the mobilities ofthe proteins identified in these "mirror image" blots were identical (not shown). From these results we concluded that rat intestine contains one or more proteins functionally and immunochemically related to P-450p.
Immunoblots of microsomes prepared from human villus with purified HLp (Fig. 3 , lane HLp) and with immunoreactive HLp in human liver microsomes (Fig. 3, lane liver) . Immunoblot analysis of enterocyte microsomes prepared from patients E-K also revealed in each a 13-7-10-reactive protein that was indistinguishable from HLp (not shown). Furthermore, the intensity of the bands produced by enterocyte microsomes was similar in all ten patients studied and was comparable with that produced by an identical amount (25 ug) of human liver microsomes (Fig. 3) . We used quantitative analysis of immunoblots to measure the amounts of 13-7-1 0-reactive protein in human enterocyte microsomes, taking the assumption that 13-7-10 has equal affinity for the proteins it identifies in intestine and liver (HLp). Calculated in this way (Table I) (Table I) . Indeed, the specific concentration of 13-7-10-reactive protein in intestinal villus tip cells actually exceeds the total concentration of cytochrome P-450 measured as CO-binding hemoprotein (Table I ). In the liver, however, the concentration of immunoreactive HLp accounts for one-fifth of the CObinding hemoprotein present.
Induction of P-450p-related cytochromes in rat intestinal mucosa. Next, we investigated whether glucocorticoids could induce the intestinal protein(s) immunochemically and functionally related to P-450p and HLp. Enterocytes from treated and control animals were dissociated from jejunum segments in five sequential cell fractions. Alkaline phosphatase activity was high in the cell lysate of fraction 1 (1.40 U/mg), in good agreement with that reported for villus tip cells (15) . The alkaline phosphatase activity we obtained in cell fraction 5 (0.1 1 U/mg) is consistent with cells from the "crypt zone" (15) . Treatment of rats with dexamethasone resulted only in a slight diminution of alkaline phosphatase activity in each cell fraction when compared with control (Fig. 4 A) . Therefore, it can be concluded that enterocyte fractions 1 and 5 isolated from both treated and untreated rats were highly enriched in cells from the villus tip and crypt regions, respectively (Fig. 4 A) .
When microsomes prepared from each cell fraction from ) . In control animals, the amounts of lG8-reactive protein (Fig. 4 B) were the same among the enterocyte populations (except in the crypt region, fraction 5, where reactive protein was detectable but could not be quantitated). In contrast, there was a gradient in the amounts of 13-7-10-reactive protein in the same samples, the highest concentration being found in the villus tip cells (Fig. 4 C) . Dexamethasone treatment increased by as much as 10-fold the amounts of 1G8-reactive protein, but only in the midportion of the villus (highest in fraction 2) and not in fractions 4 and 5 (Fig. 4 B) . In contrast, the 13-7-10-reactive protein was induced three-to fourfold in each fraction, including fraction 5 (Fig. 4 C) . These results, confirmed in duplicate experiments, suggest that 1G8 and 13-7-10 likely identify different glucocorticoid-inducible proteins in rat enterocytes.
We were unable to detect microsomal erythromycin demethylase activity in the mucosal cells harvested by the method of Weiser (15) (data not shown). Therefore, we harvested enterocytes at 4°C and found that the alkaline phosphatase activities of the initial and final (fourth) fractions were 1.60 and 0.45 U/mg, respectively. By comparing the respective alkaline phosphatase activities in the five cell fractions obtained by the standard technique (Fig. 4 A) , we concluded that at 40C cells had not been harvested from the crypt region. Microsomal erythromycin demethylase activity was readily detected in mucosal cells obtained at 4VC (Fig. 4 D) and was induced by dexamethasone treatment (twofold) although not in proportion to the increases in 1G8 (10-fold) or 13-7-10 (threefold) immunoreactive proteins. Enzyme activity was inhibited (> 80%) when enterocyte microsomes from control or dexamethasone-treated rats were incubated with anti-P-450p IgG (data not shown). Because the monoclonal antibodies do not block catalytic activity in liver microsomes (unpublished results), we were unable to test directly which intestinal protein(s) catalyzed erythromycin demethylation. However, the erythromycin demethylase activity along the villus appears to correlate better with the amount of 1G8-reactive proteins (Fig. 4) .
Identification of P-450p-related messenger RNA (mRNA) in intestinal mucosa. RNA extracted from intestinal villus tip cells of untreated and dexamethasone-treated rats was analyzed on Northern blots hybridized with pDexl2 (9), a 1.2-kilobase (kb) cDNA probe encoding the 3' half of P-450p mRNA. This cDNA probe hybridized with RNA species of approximately the same size (2.1 kb) in enterocyte RNA and in liver RNA extracted from untreated male rats (Fig. 5) . Dexamethasone treatment reproducibly increased the amount of pDex 12-hybridizable RNA in the intestine (Fig. 5 ). This effect of dexamethasone was selective inasmuch as rehybridization of this blot with a ,B-actin cDNA gave signals that were of equal intensity in the two intestinal RNA samples (data not shown).
In a similar experiment, human RNA extracted from the villus tip cells of two patients (E and F) and poly(A+) RNA prepared from the livers oftwo patients (10 and 9) was hybridized on a Northern blot with Hp55s (1 1), a 170-basepair cDNA representing the 5' region of HLp mRNA (11) . This cDNA probe hybridized with two species of RNA (Fig. 6 A) . The mobilities of the hybridizing RNA species in the intestine were the same as those for the human liver RNA (Fig. 6 A) (11) . Additional Northern blot analyses were performed to compare the Hp55s hybridization signal from equal amounts (10 MLg) of total human intestinal RNA and total human liver RNA (Fig. 6 B) . Since no RNA species has yet been demonstrated to be present in identical concentrations in liver and intestinal RNA (RNA hybridizing with f3-actin cDNA is not [29] ), it was not possible to assure by rehybridization that identical amounts of total RNA had been assayed. However, in several experiments, the amount of human intestinal RNA hybridizing with Hp55s greatly exceeded that observed in comparable amounts ofthe human liver RNA (Fig. 6 B, data not shown). These results with Hp55s are specific for HLp mRNA inasmuch as cDNAs for other human liver cytochromes P4SO, HLj (30) and HLg (31) , failed to hybridize to intestinal RNA from patients E and F (data not shown).
Discussion
The experiments presented show that the intestinal mucosa contains glucocorticoid-inducible cytochromes that are immunochemically, functionally, and genetically related to some of the glucocorticoid-inducible cytochromes of the liver. Also, these cytochromes appear to represent major isozymes present in the intestinal mucosa of untreated rats. It has been recently reported ( 16) that in rats treated with phenobarbital there is an increase in CO-binding hemoprotein in the intestinal mucosa accompanied by the appearance of a protein in enterocyte microsomes indistinguishable on immunoblots from the major phenobarbital-inducible cytochrome (P-450b [27] ) present in the liver. Similarly, administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rats results in the appearance of P-450c (27) in liver and of a protein in the intestinal mucosa that is immunochemically indistinguishable from P-450c (32). In aggregate, these data suggest that as a portal ofentry into the body, the intestine contains representatives of several of the families of liver cytochromes P-450. Moreover, we are unaware of previous reports on human intestinal cytochromes P-450. The human intestinal cytochrome we found matches human liver cytochrome HLp in its reactivity with 13-7-10 ( Fig. 2) , its mobility in polyacrylamide gels (Fig. 2) , and its ability to catalyze erythromycin N-demethylation (Fig. 1 , Table I ). Furthermore, human intestinal RNA species intensely and selectively hybridized to Hp55s, a cDNA that corresponds to the 5' end of the mRNA that encodes HLp (Fig. 6 A and B).
Rat liver contains multiple proteins (28) and mRNAs (33) related to P-450p. Evidence presented here suggests that the rat enterocyte also may contain multiple "P-450-like" proteins rather than a single protein reactive with both the 1G8 and the 13-7-10 monoclonal antibodies. First, the magnitude of dexamethasone induction ofthe IG8-reactive protein (10-fold) was considerably greater than the degree of induction of the 13-7-10-reactive protein (threefold) (Figs. 4 B and C) . Furthermore, after treatment with dexamethasone, the highest specific content of the 13-7-10-reactive protein was found in cells harvested from the tip of the villus, whereas the greatest reactivity with 1G8 was found in a population of cells located closer to the intestinal crypts (Figs. 4 B and C) . Lastly, we have observed that intestinal microsomes rapidly lose their reactivity with 1G8 upon storage at 4°C, whereas reactivity with 13-7-10 is stable (unpublished observations). It is likely that one or both of the P-450p-related intestinal proteins are functional cytochromes P-450 because erythromycin demethylase activity was inhibited by anti-P-450p IgG and was induced in the enterocyte microsomes by dexamethasone treatment (Fig.  4) . Even though the intestinal P-450p-related cytochromes and their corresponding mRNAs (Fig. 5) are induced by dexamethasone, as is P-450p in rat liver (9, 18) , purification and sequencing of the intestinal cytochromes identified in this report will be required for definitive proof of their identity.
It is the accepted notion that intestinal crypt cells are "undifferentiated" (34). For example, intestinal crypt cells contain neither detectable CO-binding hemoprotein nor immunoreactive P-450b (16) . Furthermore, unlike hepatocytes or villus cells, crypt cells do not respond to phenobarbital with induction of P-450b (16) . In contrast, we found that lG8-reactive and 13-7-10-reactive proteins were detectable in cells harvested from the crypt zone in untreated animals (although the amounts of both proteins were too low to quantitate). Moreover, 13-7-10-reactive proteins were induced by dexamethasone in crypt cells (Fig. 4 C) implying that the receptor postulated to mediate induction of glucocorticoid-inducible cytochromes in rat liver (8) may be intact and operational. It is unlikely that the induction of 13-7-10-reactive protein detected in the crypt region represented contamination with villus cells because the alkaline phosphatase activity in the crypt cell population was low (Fig. 4) and there was a threefold increase in the concentration of 13-7-10-reactive protein along the entire villus to crypt gradient (Fig. 2 B) . Because expression of P-450p protein in the liver of untreated rats is restricted to the adult (35) , crypt cells should be examined for other differentiated functions.
Although it is widely believed that the specific content of cytochrome P-450 in liver far exceeds that in intestinal mucosa, our data suggest that this is not the case for HLp-related cytochrome(s) in man. The specific content of the intestinal cytochrome in villus tip cells, measured as erythromycin demethylase activity or immunochemically as 13-7-10-reactive protein, was comparable with that observed in the livers of patients (Table I) , and the concentration of HLp-related RNA was significantly higher in the enterocyte (Fig. 6 B) . Indeed, the concentration of the intestinal cytochrome measured immunochemically exceeded measurements oftotal CO-binding hemoprotein in microsomes prepared from human villus tip cells. This discrepancy between holocytochrome and immunoreactive protein may reflect true excess apoprotein in enterocytes, overestimation of apoprotein by immunochemical techniques, or underestimation in vitro of holocytochrome P-450 concentration in intestinal mucosa in vivo. Although it is possible that preoperative fasting, obesity, or treatment with cimetidine influenced the regulation of this intestinal cytochrome, we conclude that the HLp-related protein appears to be the major cytochrome P450 in human jejunal mucosa.
Finding an abundant P-450p-related cytochrome in human jejunal mucosa enhances the idea of the intestine as a clinically important site ofmetabolism. For example, although des-N-methyl erythromycin is formed by liver P-450p after erythromycin is administered intravenously to rats, this metabolite is more abundant in the intestinal lumen than it is in bile (68 and 55%, respectively, of the total erythromycin present [36] ). The intestinal cytochromes identified in this report would account for continued metabolism of erythromycin entering the intestinal lumen either in bile or by nonbiliary pathways (37) . This is likely to be clinically important because des-N-methyl erythromycin is less biologically active and more poorly absorbed from the digestive tract than is erythromycin (36, 38) and fecal excretion is the major route of elimination for erythromycin (36, 38, 39) . The pronounced loss in bioavailability of orally administered erythromycin, which is not explained by "first pass" liver metabolism (40) , may also be attnibuted in part to intestinal HLp. Finally, since HLp is closely related, or identical, to P-450NF (41, 42), a human liver cytochrome P-450 recently characterized by Guengerich et al., the substrate specificity of HLp also likely includes nifidepine (41) , aldrin (41) , quinidine (43), and endogenous steroid hormones (41) . The finding of HLp-related cytochromes in high specific concentrations in human jejunal mucosa should prompt a reevaluation of the role-played by intestinal metabolism in the fate of many clinically important compounds.
